This inventor holds 1 USPTO granted patent. Top assignees: Ciba-Geigy Ag, Institute of Microbiology and Epidemiology, Academy of Military Medical. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1997
Title: Dianxi Ning: Innovator in Antimalarial Compositions
Introduction
Dianxi Ning is a notable inventor based in Beijing, China. He has made significant contributions to the field of medicine, particularly in the development of antimalarial compositions. His work addresses the pressing issue of drug-resistant malaria, which poses a significant threat to global health.
Latest Patents
Dianxi Ning holds a patent for an innovative antimalarial composition. This composition includes the antimalarial agent benflumetol, combined with an agent from the artemisinin group, such as artemether. The formulation can be developed into solid dosage forms, such as tablets, making it a practical solution for treating drug-resistant malaria. His patent is a crucial advancement in the fight against this disease, showcasing his commitment to improving healthcare.
Career Highlights
Throughout his career, Dianxi Ning has worked with reputable organizations, including Ciba-Geigy AG and the Institute of Microbiology and Epidemiology at the Academy of Military Medical Sciences. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his research and development capabilities.
Collaborations
Dianxi Ning has collaborated with notable colleagues, including Chengqi Shan and Yiqing Zhou. These partnerships have contributed to the success of his research and the development of effective antimalarial treatments.
Conclusion
Dianxi Ning's contributions to the field of antimalarial compositions highlight his innovative spirit and dedication to addressing global health challenges. His work not only advances medical science but also offers hope in the fight against malaria.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile